Abacus Life, Inc. (ABL)
(Delayed Data from NSDQ)
$10.78 USD
+0.76 (7.59%)
Updated Jul 23, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ABL 10.78 +0.76(7.59%)
Will ABL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ABL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABL
Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?
ABL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ABL
Western Alliance Posts Upbeat Earnings, Joins Abacus Life, SLB And Other Big Stocks Moving Higher On Friday
Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT)
Maintained Buy Rating for Abbott Laboratories on Strong Financials and Growth Prospects
Abacus Life Provides Preliminary Second Quarter 2024 Results
Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA